6 Results for "

6-Isopentenyloxyisobergapten

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "6-Isopentenyloxyisobergapten" in MCE Product Catalog:

Cat. No.: HY-W748468
CAS No.: 24099-29-4
6-Isopentenyloxyisobergapten is a furanocoumarin found in the aerial parts of Semenovia transiliensis and the roots of Heracleum maximum. 6-Isopentenyloxyisobergapten has both selective phytotoxicity and antimycobacterial activity. 6-Isopentenyloxyisobergapten shows a minimum inhibitory concentration (MIC) of 166.5 μM and an IC50 of 27.4 μM against Mycobacterium tuberculosis H37Ra. 6-Isopentenyloxyisobergapten has an IC50 of 29 μM for the growth inhibition of Lemna paucicostata. 6-Isopentenyloxyisobergapten exhibits higher activity against Agrostis stolonifera than Lactuca sativa at a concentration of 1000 μM .
loading...
    loading...
Cat. No.: HY-P3350
CAS No.: 2892148-58-0
Target:  

Bacterial

Research Areas:  

Infection

LS-BF1 is a stable and low toxic cationic antimicrobial peptide. LS-BF1 displays broad spectrum of antibacterial activity, including the challenging ESKAPE pathogens, by cell membrane disruptive mechanism. LS-BF1 shows good in vivo efficacy for elimination of bacteria in a mouse infection model[1].
loading...
    loading...
Cat. No.: HY-P2266
CAS No.: 1453222-26-8
Research Areas:  

Cancer

SAH-EZH2, a stable EZH2 α-helical peptide, is an EZH2/EED interaction inhibitor. SAH-EZH2 targets native embryonic ectoderm development (EED), disturbs its interactions with EZH1 and EZH2, and selectively decreases trimethylation of H3K27 .
loading...
    loading...
Cat. No.: HY-P10652
CAS No.: 2094604-98-3
Target:  

Wnt β-catenin

Research Areas:  

Cancer

hsBCL9CT-24 is a Wnt/β-catenin (b-cat) pathway inhibitor with potent anti-tumor effect. hsBCL9CT-24 reactivates anti-cancer immune response suppressed by the oncogenic Wnt pathway and can be utilized for cancer research .
loading...
    loading...
Cat. No.: HY-P5559
CAS No.: 2582803-80-1
Target:  

PROTACs

Research Areas:  

Cancer

ND1-YL2 is a PROTAC that selectively degrades SRC-1 via the N-degron pathway. ND1-YL2 significantly inhibits cancer invasion and migration in vitro and in vivo. ND1-YL2 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-P10386
Target:  

Bcl-2 Family

Research Areas:  

Cancer

155H1 (Compound 11) is a stapled peptide, that covalently binds hMcl1 (172-323) with IC50 of 18 nM .
loading...
    loading...